Table 1 Distribution of clinicopathological features by HIF-1α expression
Variable | HIF-1 α <19 | HIF-1 α⩾19 | P |
|---|---|---|---|
Gender | |||
Male | 54 (47) | 60 (53) | 0.18 |
Female | 15 (65) | 8 (35) | |
Age (years) | |||
<75 | 38 (58) | 27 (42) | 0.1 |
⩾75 | 31 (43) | 41 (57) | |
Stage | |||
1 | 2 (40) | 3 (60) | 0.91 |
2 | 51 (50) | 50 (50) | |
3 | 14 (54) | 12 (46) | |
4a | 2 (40) | 3 (60) | |
TURBT | |||
Complete | 24 (46) | 28 (54) | 0.31 |
Partial | 22 (47) | 25 (53) | |
Biopsy | 21 (62) | 13 (38) | |
Necrosis | |||
Absent | 38 (59) | 26 (41) | 0.07 |
Present | 31 (42) | 42 (58) | |
Growth pattern | |||
Papillary | 7 (50) | 7 (50) | 0.4 |
Solid | 37 (56) | 29 (44) | |
Both | 25 (44) | 32 (56) | |
CIS | |||
Absent | 45 (46) | 52 (54) | 0.21 |
Present | 24 (60) | 16 (40) | |
Hb (g dl−1) | |||
<14 | 43 (57) | 33 (63) | 0.15 |
⩾14 | 26 (43) | 35 (57) | |
CAIX | |||
0 | 34 (65) | 18 (35) | 0.004 |
>0 | 30 (38) | 49 (62) | |
GLUT1 | |||
<100 | 36 (60) | 24 (40) | 0.006 |
⩾100 | 22 (34) | 43 (66) | |
